RespireRx Pharmaceuticals Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q2 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
RespireRx Pharmaceuticals Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q2 2010 to Q3 2023.
  • RespireRx Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2023 was -$396K, a 16.3% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2023 was -$1.8M, a 30.6% increase year-over-year.
  • RespireRx Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$2.1M, a 33.1% increase from 2021.
  • RespireRx Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$3.14M, a 26.9% increase from 2020.
  • RespireRx Pharmaceuticals Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$4.3M, a 103% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$1.8M -$396K +$77.1K +16.3% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-17
Q2 2023 -$1.87M -$681K -$201K -41.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-11-17
Q1 2023 -$1.67M -$430K +$430K +50% Jan 1, 2023 Mar 31, 2023 10-Q 2023-11-17
Q4 2022 -$2.1M -$290K +$484K +62.6% Oct 1, 2022 Dec 31, 2022 10-Q 2023-05-22
Q3 2022 -$2.59M -$473K +$236K +33.3% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-17
Q2 2022 -$2.82M -$480K +$332K +40.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-17
Q1 2022 -$3.15M -$860K -$9.91K -1.17% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-17
Q4 2021 -$3.14M -$774K +$285K +26.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-04-17
Q3 2021 -$3.43M -$709K +$771K +52.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-17
Q2 2021 -$4.2M -$812K +$3.92K +0.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-17
Q1 2021 -$4.2M -$850K +$96.5K +10.2% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-17
Q4 2020 -$4.3M -$1.06M -$431K -68.7% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-15
Q3 2020 -$3.87M -$1.48M -$1.01M -215% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.86M -$816K -$339K -71% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-15
Q1 2020 -$2.52M -$947K -$406K -75.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-08-16
Q4 2019 -$2.12M -$628K +$46.3K +6.87% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-15
Q3 2019 -$2.16M -$470K +$65.9K +12.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-23
Q2 2019 -$2.23M -$477K +$158K +24.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-23
Q1 2019 -$2.39M -$540K +$206K +27.6% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-23
Q4 2018 -$2.59M -$674K -$54.2K -8.75% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-14
Q3 2018 -$2.54M -$536K +$82.8K +13.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$2.62M -$635K +$949K +59.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-19
Q1 2018 -$3.57M -$747K +$722K +49.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-19
Q4 2017 -$4.29M -$620K +$806K +56.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-16
Q3 2017 -$5.1M -$619K +$1.77M +74.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$6.87M -$1.58M +$1.15M +42% Apr 1, 2017 Jun 30, 2017 10-Q 2018-10-15
Q1 2017 -$8.02M -$1.47M +$1.21M +45.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-21
Q4 2016 -$9.23M -$1.43M +$295K +17.1% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$9.52M -$2.39M -$128K -5.66% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$9.4M -$2.73M -$1.48M -119% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$7.91M -$2.68M -$1.95M -268% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-19
Q4 2015 -$5.96M -$1.72M -$974K -131% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$4.99M -$2.26M -$1.62M -252% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 -$3.37M -$1.25M -$1.31M -2102% Apr 1, 2015 Jun 30, 2015 10-Q/A 2016-08-12
Q1 2015 -$2.05M -$728K +$653K +47.3% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-13
Q4 2014 -$2.71M -$746K -$663K -798% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-29
Q3 2014 -$2.04M -$643K -$542K -536% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$1.5M $62.4K +$242K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$1.74M -$1.38M -$543K -64.9% Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-08-07
Q4 2013 -$1.2M -$83.1K +$3.79M +97.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-30
Q3 2013 -$4.99M -$101K +$1.67M +94.3% Jul 1, 2013 Sep 30, 2013 10-Q 2015-03-09
Q2 2013 -$6.66M -$180K +$815K +81.9% Apr 1, 2013 Jun 30, 2013 10-Q 2015-02-24
Q1 2013 -$7.48M -$837K +$96.4K +10.3% Jan 1, 2013 Mar 31, 2013 10-Q 2015-02-10
Q4 2012 -$7.57M -$3.87M -$4.7M -566% Oct 1, 2012 Dec 31, 2012 10-K 2015-01-06
Q3 2012 -$2.87M -$1.77M -$596K -50.7% Jul 1, 2012 Sep 30, 2012 10-Q 2014-12-15
Q2 2012 -$2.27M -$995K -$639K -179% Apr 1, 2012 Jun 30, 2012 10-Q 2014-12-15
Q1 2012 -$1.63M -$934K +$622K +40% Jan 1, 2012 Mar 31, 2012 10-Q 2014-11-24
Q4 2011 -$2.26M $832K Oct 1, 2011 Dec 31, 2011 10-K 2014-10-14
Q3 2011 -$1.17M -$647K -122% Jul 1, 2011 Sep 30, 2011 10-Q 2014-07-30
Q2 2011 -$356K +$2.1M +85.5% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-16
Q1 2011 -$1.56M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q3 2010 -$528K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$2.45M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.